anmelden
25 € WM-Startbonus auf dein Cash-Konto
BX Swiss TOP 30 CHF
1.480,29
PKT
-6,17
PKT
-0,42
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.06.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
| 26.06.12 | UBS outperform | RBC Capital Markets | |
| 26.06.12 | Kühne + Nagel International buy | Nomura | |
| 26.06.12 | Adecco SA buy | Sarasin Research | |
| 26.06.12 | Adecco SA buy | Vontobel Research | |
| 25.06.12 | UBS buy | Banc of America Securities-Merrill Lynch | |
| 25.06.12 | Holcim neutral | J.P. Morgan Cazenove | |
| 25.06.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 25.06.12 | Novartis neutral | UBS AG | |
| 25.06.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 25.06.12 | UBS neutral | Banc of America Securities-Merrill Lynch | |
| 25.06.12 | Novartis buy | UBS AG | |
| 25.06.12 | UBS kaufen | Die Actien-Börse | |
| 25.06.12 | Sonova buy | Vontobel Research | |
| 25.06.12 | UBS hold | Vontobel Research | |
| 22.06.12 | Richemont overweight | Barclays Capital | |
| 22.06.12 | Novartis outperform | Credit Suisse Group | |
| 22.06.12 | Holcim overweight | HSBC | |
| 22.06.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 22.06.12 | Holcim overweight | HSBC | |
| 22.06.12 | Swiss Life buy | Deutsche Bank AG | |
| 22.06.12 | Lonza outperform | Cheuvreux SA | |
| 22.06.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 22.06.12 | Roche neutral | Nomura | |
| 22.06.12 | Holcim hold | Vontobel Research | |
| 21.06.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 21.06.12 | ABB (Asea Brown Boveri) buy | Goldman Sachs Group Inc. | |
| 20.06.12 | Holcim sell | Citigroup Corp. | |
| 20.06.12 | Roche neutral | Citigroup Corp. | |
| 20.06.12 | Holcim buy | Citigroup Corp. | |
| 20.06.12 | UBS buy | Citigroup Corp. | |
| 20.06.12 | Nestlé hold | Vontobel Research | |
| 19.06.12 | Roche neutral | J.P. Morgan Cazenove | |
| 19.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 19.06.12 | Julius Bär buy | Sarasin Research | |
| 19.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 19.06.12 | Julius Bär hold | Vontobel Research | |
| 18.06.12 | Holcim buy | UBS AG | |
| 18.06.12 | ABB (Asea Brown Boveri) neutral | J.P. Morgan Cazenove | |
| 18.06.12 | Nestlé hold | Vontobel Research |